Documentation scienceplus.abes.fr version Bêta

À propos de : Hypertension in type 2 diabetes - targeting angiotensin        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Hypertension in type 2 diabetes - targeting angiotensin
has manifestation of work
Abstract
  • Cardiovascular disease accounts for around 60% of deaths in people with type 2 diabetes mellitus, and diabetes is the leading cause of renal dysfunction and premature death in the UK.1,2 A key factor in these outcomes is that many people with type 2 diabetes also have raised blood pressure, which increases the likelihood of vascular complications.3-5 Lowering elevated blood pressure, using one or more antihypertensive drugs, reduces illness and mortality rates in such people.6,7 National guidelines advocate the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin-II receptor antagonists in selected patients with type 2 diabetes.3,8,9 Here we review whether such treatment offers advantages over other antihypertensive drugs.
article type
publisher identifier
  • dtdt0506
Alternative Title
  • Hypertension in type 2 diabetes - targeting angiotensin
is part of this journal
PubMed ID
  • 15966556



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata